Bansal Medilab Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 15-12-2024
- Paid Up Capital ₹ 1.19 M
as on 15-12-2024
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.98 Cr
as on 15-12-2024
- Satisfied Charges ₹ 4.41 Cr
as on 15-12-2024
- Revenue -15.83%
(FY 2021)
- Profit 23.35%
(FY 2021)
- Ebitda 8.12%
(FY 2021)
- Net Worth 16.36%
(FY 2021)
- Total Assets 41.31%
(FY 2021)
About Bansal Medilab
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.19 M.
The company currently has active open charges totaling ₹8.98 Cr. The company has closed loans amounting to ₹4.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surendra Bansal, Anadi Bansal, and Purvi Bansal serve as directors at the Company.
- CIN/LLPIN
U85195WB1988PTC044289
- Company No.
044289
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bansal Medilab?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Bansal  | Director | 29-Apr-1988 | Current |
| Anadi Bansal | Director | 06-Jul-2015 | Current |
| Purvi Bansal | Director | 07-Nov-2017 | Current |
Financial Performance of Bansal Medilab.
Bansal Medilab Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 15.83% decrease. The company also saw a substantial improvement in profitability, with a 23.35% increase in profit. The company's net worth Soared by an impressive increase of 16.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bansal Medilab?
Unlock access to Bansal Medilab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹89.80 M
₹44.14 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 8.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2021 | Axis Bank Limited | ₹8.98 Cr | Open |
| 27 Nov 2020 | Others | ₹1.34 Cr | Satisfied |
| 30 Apr 2019 | Others | ₹0.80 M | Satisfied |
| 15 Jun 2017 | Others | ₹4.00 M | Satisfied |
| 09 Jul 2016 | Others | ₹3.26 M | Satisfied |
How Many Employees Work at Bansal Medilab?
Bansal Medilab has a workforce of 60 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bansal Medilab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Medilab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
